Detalhe da pesquisa
1.
Synthetic Lethal and Resistance Interactions with BET Bromodomain Inhibitors in Triple-Negative Breast Cancer.
Mol Cell
; 78(6): 1096-1113.e8, 2020 06 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-32416067
2.
Inhibition of EZH2 transactivation function sensitizes solid tumors to genotoxic stress.
Proc Natl Acad Sci U S A
; 119(3)2022 01 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-35031563
3.
Anti-CD47 immunotherapy in combination with BCL-2 inhibitor to enhance anti-tumor activity in B-cell lymphoma.
Hematol Oncol
; 40(4): 596-608, 2022 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-35477179
4.
Comparison analysis of first-line asparaginase- versus non-asparaginase-based regimens for early-stage extranodal NK/T-cell lymphoma.
Ann Hematol
; 101(9): 2021-2034, 2022 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-35798977
5.
Response and resistance to BET bromodomain inhibitors in triple-negative breast cancer.
Nature
; 529(7586): 413-417, 2016 Jan 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-26735014
6.
FIPRESCI: droplet microfluidics based combinatorial indexing for massive-scale 5'-end single-cell RNA sequencing.
Genome Biol
; 24(1): 70, 2023 04 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-37024957
7.
The Lin28b/Wnt5a axis drives pancreas cancer through crosstalk between cancer associated fibroblasts and tumor epithelium.
Nat Commun
; 14(1): 6885, 2023 10 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-37898598
8.
De novo genes with an lncRNA origin encode unique human brain developmental functionality.
Nat Ecol Evol
; 7(2): 264-278, 2023 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-36593289
9.
Combination Therapies to Improve the Efficacy of Immunotherapy in Triple-negative Breast Cancer.
Mol Cancer Ther
; 22(11): 1304-1318, 2023 Nov 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37676980
10.
JAK-STAT Signaling in Inflammatory Breast Cancer Enables Chemotherapy-Resistant Cell States.
Cancer Res
; 83(2): 264-284, 2023 01 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-36409824
11.
Heterogeneity and transcriptional drivers of triple-negative breast cancer.
Cell Rep
; 42(12): 113564, 2023 12 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-38100350
12.
Phosphorylation and activation of androgen receptor by Aurora-A.
J Biol Chem
; 291(43): 22854, 2016 10 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-27825092
13.
IKKϵ phosphorylation of estrogen receptor α Ser-167 and contribution to tamoxifen resistance in breast cancer.
J Biol Chem
; 291(43): 22857, 2016 10 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-27825095
14.
Phosphoinositide 3-kinase/Akt inhibits MST1-mediated pro-apoptotic signaling through phosphorylation of threonine 120.
J Biol Chem
; 291(43): 22858, 2016 10 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-27825096
15.
Phosphorylation and activation of androgen receptor by Aurora-A.
J Biol Chem
; 285(43): 33045-33054, 2010 Oct 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-20713353
16.
Phosphoinositide 3-kinase/Akt inhibits MST1-mediated pro-apoptotic signaling through phosphorylation of threonine 120.
J Biol Chem
; 285(6): 3815-3824, 2010 Feb 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-19940129
17.
IKKepsilon phosphorylation of estrogen receptor alpha Ser-167 and contribution to tamoxifen resistance in breast cancer.
J Biol Chem
; 285(6): 3676-3684, 2010 Feb 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-19940156
18.
Correlation of mutational landscape and survival outcome of peripheral T-cell lymphomas.
Exp Hematol Oncol
; 10(1): 9, 2021 Feb 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-33546774
19.
Deregulation of IKBKE is associated with tumor progression, poor prognosis, and cisplatin resistance in ovarian cancer.
Am J Pathol
; 175(1): 324-33, 2009 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-19497997
20.
Therapy of Primary Liver Cancer.
Innovation (Camb)
; 1(2): 100032, 2020 Aug 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-32914142